| |  Online-Ressource |
|---|
| Verfasst von: | Blasi, Miriam [VerfasserIn]  |
|---|
| | Eichhorn, Martin E. [VerfasserIn] |
|---|
| | Christopoulos, Petros [VerfasserIn] |
|---|
| | Winter, Hauke [VerfasserIn] |
|---|
| | Heußel, Claus Peter [VerfasserIn] |
|---|
| | Herth, Felix [VerfasserIn] |
|---|
| | El-Shafie, Rami [VerfasserIn] |
|---|
| | Kriegsmann, Katharina [VerfasserIn] |
|---|
| | Kriegsmann, Mark [VerfasserIn] |
|---|
| | Stenzinger, Albrecht [VerfasserIn] |
|---|
| | Bischoff, Helge [VerfasserIn] |
|---|
| | Thomas, Michael [VerfasserIn] |
|---|
| | Kuon, Jonas [VerfasserIn] |
|---|
| Titel: | Major clinical benefit from adjuvant chemotherapy for stage II-III non-small cell lung cancer patients aged 75 years or older |
|---|
| Titelzusatz: | a propensity score-matched analysis |
|---|
| Verf.angabe: | Miriam Blasi, Martin E. Eichhorn, Petros Christopoulos, Hauke Winter, Claus Peter Heußel, Felix J. Herth, Rami El Shafie, Katharina Kriegsmann, Mark Kriegsmann, Albrecht Stenzinger, Helge Bischoff, Michael Thomas, and Jonas Kuon |
|---|
| E-Jahr: | 2022 |
|---|
| Jahr: | 28 June 2022 |
|---|
| Umfang: | 8 S. |
|---|
| Fussnoten: | Gesehen am 18.08.2022 |
|---|
| Titel Quelle: | Enthalten in: BMC pulmonary medicine |
|---|
| Ort Quelle: | London : BioMed Central, 2001 |
|---|
| Jahr Quelle: | 2022 |
|---|
| Band/Heft Quelle: | 22(2022), Artikel-ID 255, Seite 1-8 |
|---|
| ISSN Quelle: | 1471-2466 |
|---|
| Abstract: | Data are currently insufficient to support the use of adjuvant chemotherapy (ACT) after surgical resection for stage II or III non-small cell lung cancer (NSCLC) in patients aged ≥ 75 years. In this study we evaluated efficacy and safety profile of ACT in this population. |
|---|
| DOI: | doi:10.1186/s12890-022-02043-6 |
|---|
| URL: | kostenfrei: Volltext: https://doi.org/10.1186/s12890-022-02043-6 |
|---|
| | DOI: https://doi.org/10.1186/s12890-022-02043-6 |
|---|
| Datenträger: | Online-Ressource |
|---|
| Sprache: | eng |
|---|
| Sach-SW: | Non-small cell lung cancer |
|---|
| | Adjuvant chemotherapy |
|---|
| | Elderly |
|---|
| K10plus-PPN: | 181465836X |
|---|
| Verknüpfungen: | → Zeitschrift |
|---|
| |
|
|---|
| | |
|---|
| Lokale URL UB: |  Zum Volltext |
|---|
Major clinical benefit from adjuvant chemotherapy for stage II-III non-small cell lung cancer patients aged 75 years or older / Blasi, Miriam [VerfasserIn]; 28 June 2022 (Online-Ressource)
